NCI-Supported Programs

Multidisciplinary programs include laboratory scientists, clinical investigators, providers of patient care, epidemiologists, and sociobehavioral scientists. Collaboration across disciplines ensures that insights gained in the lab can move quickly and effectively to cancer patients' bedsides and to cancer prevention and control programs. The following multidisciplinary research programs are supported by the National Cancer Institute Cancer Center Support Grant.

Roster of Program Leadership

Breast Oncology

Program Leaders: Laura J. Esserman, MD, MBA; Laura J. van ‘t Veer, PhD; Andrei Goga, MD, PhD
Education and Training Liaison: Nicolas Prionas, MD, PhD
Community Engagement Liaison: Kimberly Badal, PhD

Cancer Control

Program Leaders: Scarlett Lin-Gomez, MPH, PhD; Pamela Ling, MD; Tung T. Nguyen, MD
Education and Training Liaison: Gideon St. Helen, PhD
Community Engagement Liaison: Sorbarikor Piawah, MD

Cancer Immunology & Immunotherapy

Program Leaders: Thomas G. Martin, MD 
Education and Training Liaison: Hilde Schjerven, PhD
Community Engagement Liaison: Katy Tsai, MD

Molecular Oncology

Program Leaders: Charles S. Craik, PhD; Pamela Munster, MD
Education and Training Liaison: Michael Cheng, MD
Community Engagement Liaison: TBA

Neurologic Oncology

Program Leaders: Nicholas Butowski, MD; Susan M. Chang, MD; Manish Aghi, MD, PhD
Education and Training Liaison: Nancy Ann Oberheim Bush, MD, PhD
Community Engagement Liaison: Jennie Taylor, MD

Pediatric Malignancies

Program Leaders: Sabine Mueller, MD, PhD; Alejandro Sweet-Cordero, MD; William A. Weiss, MD, PhD
Education and Training Liaison: Christine Higham, MD
Community Engagement Liaison: Lena Winestone, MD

Prostate Cancer

Program Leaders: Matthew Cooperberg, MD, MPH; Felix Feng, MD; Eric J. Small, MD
Education and Training Liaison: Sima Porten, MD, MPH
Community Engagement Liaison: Samuel Washington III, MD, MAS

Image
Breast Cancer Cells

Breast Oncology

The goal of the Breast Oncology Program is to reduce the risk of breast cancer development, progression, and mortality through innovative approaches that utilize the molecular, cellular, and targetable networks underlying breast cancer susceptibility, heterogeneity, and disparities in outcomes.
Image
Cancer Control Population Science

Cancer Control

The goal of the Cancer Control Program is to use a multi-disciplinary team approach to understand and intervene on the structural and social determinants of cancer, leading to improved cancer health outcomes and equity.
Image
Cancer Immunotherapy

Cancer Immunology & Immunotherapy

The goal of the Cancer Immunology & Immunotherapy Program is to advance the understanding of the interplay between the immune system and cancer to discover new strategies for immune-based immunotherapies and to mitigate therapeutic resistance.
Image
Cancer Therapeutics Being Developed in a Lab

Molecular Oncology

The goal of the Molecular Oncology Program is to discover, develop, and translate novel preventive and therapeutic strategies and biomarkers through cancer research that spans basic science to clinical applications and back.
Image
Chromosomes from glioblastoma cells

Neurologic Oncology

The goal of the Neurologic Oncology Program is to use a team approach to advance the understanding of brain tumor biology and drive translation toward more effective and targeted treatments.
Image
Pediatric Cancer Patient Holding Teddy Bear

Pediatric Malignancies

The goal of the Pediatric Malignancies Program is to develop more effective and less toxic therapies for cancers in infants, children, adolescents, and young adults.
Image
Prostate Cancer Cells

Prostate Cancer

The mission of the Prostate Cancer Program is to reduce the morbidity and mortality associated with prostate cancer and its treatments by leveraging a deep understanding of the disease at the biologic, clinical, and population levels.


Images courtesy of the National Cancer Institute/ NCI Cancer Closeup Collection